TopoTarget ({{OMX|CSE30074|TOPO) is an international biotechnology company focused on the discovery and development of drugs and therapies to treat cancer. While the company has offices around the world, its headquarters are based in Copenhagen, Denmark. It was founded in 2000 by a group of clinicians. TopoTarget is involved in collaborations with both academia and industry. In 2001 they began collaborating with the National Cancer Institute, a component of the US National Institutes of Health.

PropertyValue
dbpedia-owl:Company/assets
  • 619032000
dbpedia-owl:Company/equity
  • 429376000
dbpedia-owl:Company/industry
dbpedia-owl:Company/netIncome
  • 301200000
dbpedia-owl:Company/operatingIncome
  • 294370000
dbpedia-owl:Organisation/foundationDate
  • 2000-01-01 00:00:00 (xsd:date)
dbpedia-owl:Organisation/foundationPlace
dbpedia-owl:Organisation/keyPerson
dbpedia-owl:Organisation/keyPersonPosition
  • Peter Jensen, co-foundar and CEO
    Håkan Åström, Chairman
dbpedia-owl:Organisation/location
dbpedia-owl:Organisation/numberOfEmployees
  • 68 (xsd:integer)
dbpedia-owl:Organisation/revenue
  • 43890000
dbpedia-owl:Organisation/slogan
  • Answers for Cancer
dbpedia-owl:Organisation/type
dbpedia-owl:assets
  • 619032000
dbpedia-owl:equity
  • 429376000
dbpedia-owl:foundationDate
  • 2000-01-01 00:00:00 (xsd:date)
dbpedia-owl:foundationPlace
dbpedia-owl:industry
dbpedia-owl:keyPerson
dbpedia-owl:keyPersonPosition
  • Peter Jensen, co-foundar and CEO
    Håkan Åström, Chairman
dbpedia-owl:location
dbpedia-owl:netIncome
  • 301200000
dbpedia-owl:numberOfEmployees
  • 68 (xsd:integer)
dbpedia-owl:operatingIncome
  • 294370000
dbpedia-owl:revenue
  • 43890000
dbpedia-owl:slogan
  • Answers for Cancer
dbpedia-owl:thumbnail
dbpedia-owl:type
dbpprop:abstract
  • TopoTarget ({{OMX|CSE30074|TOPO) is an international biotechnology company focused on the discovery and development of drugs and therapies to treat cancer. While the company has offices around the world, its headquarters are based in Copenhagen, Denmark. It was founded in 2000 by a group of clinicians. TopoTarget is involved in collaborations with both academia and industry. In 2001 they began collaborating with the National Cancer Institute, a component of the US National Institutes of Health. Since their acquisition of Prolifix, they have been collaborating with the Netherlands Cancer Institute. They also collaborate with Rigshospitalet, the national hospital of Denmark. TopoTarget has also collaborated with other companies, including Novartis since 2003, and Lundbeck as of October 2007; Topotarget has been member of the Danish Innovation Network BioLogue since 2005.
dbpprop:companyLogo
dbpprop:companyName
  • TopoTarget
dbpprop:companySlogan
  • Answers for Cancer
dbpprop:companyType
dbpprop:foundation
  • 2000-01-01 00:00:00 (xsd:date)
dbpprop:homepage
dbpprop:industry
dbpprop:keyPeople
dbpprop:location
dbpprop:numEmployees
  • 68 (xsd:integer)
dbpprop:omxProperty
  • CSE30074
  • TOPO
dbpprop:reference
dbpprop:revenue
  • DKK 43.89 million (2008), pg. 31
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • TopoTarget ({{OMX|CSE30074|TOPO) is an international biotechnology company focused on the discovery and development of drugs and therapies to treat cancer. While the company has offices around the world, its headquarters are based in Copenhagen, Denmark. It was founded in 2000 by a group of clinicians. TopoTarget is involved in collaborations with both academia and industry. In 2001 they began collaborating with the National Cancer Institute, a component of the US National Institutes of Health.
rdfs:label
  • TopoTarget
skos:subject
foaf:depiction
foaf:homepage
foaf:name
  • TopoTarget
foaf:page
is dbpprop:disambiguates of